sophocarpine has been researched along with Fatty Liver, Nonalcoholic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YX; Fang, JQ; Qian, H; Sheng, X; Shi, J; Song, CY; Wang, Y; Zeng, X; Zhang, Y; Zheng, JM | 1 |
Chen, SW; Chen, YX; Hu, PF; Ning, BF; Shi, J; Song, CY; Xie, WF; Zeng, X; Zheng, ZW | 1 |
Chen, YX; Shi, J; Song, CY; Xie, WF; Zeng, X; Zhang, Y | 1 |
3 other study(ies) available for sophocarpine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
Topics: Alkaloids; Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Gene Expression; Hepatocytes; Inflammation Mediators; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oleic Acid; Polymerase Chain Reaction; Rats, Sprague-Dawley; Signal Transduction; Sophora; Toll-Like Receptor 4; Up-Regulation | 2015 |
Sophocarpine alleviates non-alcoholic steatohepatitis in rats.
Topics: Adipokines; Alkaloids; Animals; Anti-Inflammatory Agents; Cytokines; Cytoprotection; Disease Models, Animal; Down-Regulation; Fatty Liver; Inflammation Mediators; Lipids; Liver; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Time Factors; Transaminases | 2011 |
Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway.
Topics: Adipokines; Adiponectin; Alkaloids; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Fatty Liver; Hepatocytes; Male; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |